BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 34494908)

  • 1. BRAF-Mutated Melanoma Journey in Latin America: Expert Recommendations From Diagnosis to Treatment.
    Bravo-Garzón MA; Bornstein-Quevedo L; Camargo VP; Sanku G; Jansen AM; Macedo MP; Rico-Restrepo M; Chacón M
    Cancer Control; 2024; 31():10732748241251572. PubMed ID: 38751033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitors in melanoma.
    Carlino MS; Larkin J; Long GV
    Lancet; 2021 Sep; 398(10304):1002-1014. PubMed ID: 34509219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases.
    Amagai R; Muto Y; Kato H; Matsushita S; Maekawa T; Fukushima S; Yoshino K; Uchi H; Fujisawa Y; Yamamoto Y; Ohuchi K; Kambayashi Y; Fujimura T
    Melanoma Res; 2021 Dec; 31(6):575-578. PubMed ID: 34524222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas.
    Shen J; Yang J; Sang L; Sun R; Bai W; Wang C; Sun Y; Sun J
    Cancer Biol Med; 2021 Sep; 19(8):1211-23. PubMed ID: 34570440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
    Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D
    J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis.
    Formica V; Sera F; Cremolini C; Riondino S; Morelli C; Arkenau HT; Roselli M
    J Natl Cancer Inst; 2022 Apr; 114(4):517-527. PubMed ID: 34542636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Unusual Case of Desmoplastic Melanoma With Monster Cells Imitating an Atypical Fibroxanthoma.
    Ríos-Martín JJ; Pérez-Pérez M; Umbría-Jiménez S; Moreno-Ramírez D; Vallejo-Benítez A
    Int J Surg Pathol; 2022 May; 30(3):313-316. PubMed ID: 34541940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sellar melanocytoma.
    Claus M; Van Der Linden M; Van Dorpe J; Lapauw B; T'Sjoen G
    Pituitary; 2021 Dec; 24(6):970-977. PubMed ID: 34518998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined carboplatin and paclitaxel therapy improves overall survival in patients with nivolumab-resistant acral and mucosal melanoma.
    Maeda T; Hiura A; Uehara J; Toyoshima R; Nakagawa T; Yoshino K
    Br J Dermatol; 2022 Feb; 186(2):361-363. PubMed ID: 34510408
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review.
    Jamerson T; Rebecca VW; Aguh C
    J Natl Med Assoc; 2022 Feb; 114(1):7-11. PubMed ID: 34509302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review.
    Ramchatesingh B; Martínez Villarreal A; Arcuri D; Lagacé F; Setah SA; Touma F; Al-Badarin F; Litvinov IV
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre.
    Potter AJ; Colebatch AJ; Rawson RV; Ferguson PM; Cooper WA; Gupta R; O'Toole S; Saw RPM; Ch'ng S; Menzies AM; Long GV; Scolyer RA
    Pathology; 2022 Aug; 54(5):526-532. PubMed ID: 35249747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma proteome alterations by MAPK inhibitors in BRAF
    Babačić H; Eriksson H; Pernemalm M
    Neoplasia; 2021 Aug; 23(8):783-791. PubMed ID: 34246984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Future of Molecular Analysis in Melanoma: Diagnostics to Direct Molecularly Targeted Therapy.
    Akabane H; Sullivan RJ
    Am J Clin Dermatol; 2016 Feb; 17(1):1-10. PubMed ID: 26518880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of Targeted Therapy for Melanoma.
    Sun J; Carr MJ; Khushalani NI
    Surg Clin North Am; 2020 Feb; 100(1):175-188. PubMed ID: 31753111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflex Molecular Testing in Melanoma Diagnosis: When Should
    Zhou S; Sivachandran S; Sikorski D; Xu HH; Lagacé F; Claveau J; Salopek TG; Gniadecki R; Litvinov IV
    J Cutan Med Surg; 2022; 26(2):201-202. PubMed ID: 34494908
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of Reflex Testing for BRAF Mutational Status in Advanced Melanoma.
    Tsang M; Petkiewicz S
    Arch Pathol Lab Med; 2022 Dec; 146(12):1535-1539. PubMed ID: 35344989
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.